WO2025215470 - AMORPHOUS OTENAPROXESUL FOR THE TREATMENT OF ACUTE PAIN
National phase entry is expected:
Publication Number
WO/2025/215470
Publication Date
16.10.2025
International Application No.
PCT/IB2025/053473
International Filing Date
02.04.2025
Title **
[English]
AMORPHOUS OTENAPROXESUL FOR THE TREATMENT OF ACUTE PAIN
[French]
OTENAPROXESUL AMORPHE POUR LE TRAITEMENT DE LA DOULEUR AIGUË
Applicants **
ANTIBE THERAPEUTICS, INC.
Inventors
VAUGHAN, David J.
DAGGER, Raymond E.
GUAY, France
LEGAULT, Daniel
STAUFFER, Joseph W.
Priority Data
63/632,161
10.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4347 | |
| EPO | Filing, Examination, Granting | 50406 | |
| Japan | Filing, Examination, Granting | 3663 | |
| South Korea | Filing, Examination, Granting | 5393 | |
| USA | Filing, Examination, Granting | 14590 |
Total:
78,399
Contact Us
Abstract[English]
The present application relates to methods of treating or preventing acute pain using amorphous otenaproxesul. In particular, the present application includes methods of treating or preventing acute pain using dosing regimens of amorphous solid dispersions comprising otenaproxesul and compositions comprising the amorphous solid dispersions. The present application further relates to pharmaceutical packages and kits comprising amorphous otenaproxesul. Formula (I) (Otenaproxesul)[French]
La présente demande concerne des méthodes de traitement ou de prévention de la douleur aiguë à l'aide d'otenaproxesul amorphe. En particulier, la présente demande concerne des méthodes de traitement ou de prévention de la douleur aiguë à l'aide de schémas posologiques de dispersions solides amorphes comprenant de l'otenaproxesul et des compositions comprenant les dispersions solides amorphes. La présente demande concerne en outre des conditionnements pharmaceutiques et des kits comprenant de l'otenaproxesul amorphe.